10-93503185-C-T

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_018131.5(CEP55):​c.256C>T​(p.Arg86*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000449 in 1,613,690 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00048 ( 0 hom. )

Consequence

CEP55
NM_018131.5 stop_gained

Scores

1
4
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 0.00600
Variant links:
Genes affected
CEP55 (HGNC:1161): (centrosomal protein 55) Enables identical protein binding activity. Involved in cranial skeletal system development; establishment of protein localization; and midbody abscission. Acts upstream of or within mitotic cytokinesis. Located in Flemming body; centriolar satellite; and plasma membrane. Implicated in multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 10-93503185-C-T is Pathogenic according to our data. Variant chr10-93503185-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 437875.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP55NM_018131.5 linkc.256C>T p.Arg86* stop_gained Exon 3 of 9 ENST00000371485.8 NP_060601.4 Q53EZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP55ENST00000371485.8 linkc.256C>T p.Arg86* stop_gained Exon 3 of 9 1 NM_018131.5 ENSP00000360540.3 Q53EZ4-1

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152062
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000282
AC:
71
AN:
251356
AF XY:
0.000228
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000378
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000478
AC:
698
AN:
1461628
Hom.:
0
Cov.:
31
AF XY:
0.000446
AC XY:
324
AN XY:
727140
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
AC:
3
AN:
33478
Gnomad4 AMR exome
AF:
0.000470
AC:
21
AN:
44724
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
26128
Gnomad4 EAS exome
AF:
0.0000252
AC:
1
AN:
39688
Gnomad4 SAS exome
AF:
0.0000116
AC:
1
AN:
86252
Gnomad4 FIN exome
AF:
0.000262
AC:
14
AN:
53412
Gnomad4 NFE exome
AF:
0.000576
AC:
640
AN:
1111792
Gnomad4 Remaining exome
AF:
0.000298
AC:
18
AN:
60386
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152062
Hom.:
0
Cov.:
33
AF XY:
0.000202
AC XY:
15
AN XY:
74252
show subpopulations
Gnomad4 AFR
AF:
0.0000725
AC:
0.0000724638
AN:
0.0000724638
Gnomad4 AMR
AF:
0.000131
AC:
0.000131148
AN:
0.000131148
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.0000944
AC:
0.0000944287
AN:
0.0000944287
Gnomad4 NFE
AF:
0.000279
AC:
0.000279289
AN:
0.000279289
Gnomad4 OTH
AF:
0.000478
AC:
0.000478011
AN:
0.000478011
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000355
Hom.:
0
Bravo
AF:
0.000227
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000379
AC:
46
EpiCase
AF:
0.000763
EpiControl
AF:
0.000296

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome Pathogenic:4
Jul 22, 2020
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in compound heterozygosity with variant NM_018131.5:c.256C>T -

Aug 31, 2021
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 28, 2017
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

-
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This nonsense variant found in exon 3 of 9 and is predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a homozygous change in a fetus with a prenatal lethal phenotype consistent with Multinucleated neurons, Anhydramnios, Renal dysplasia, Cerebellar hypoplasia, and Hydranencephaly (MARCH) syndrome, and as a compound heterozygous change in an infant with microcephaly, speech delay, and bilateral toe syndactyly (MIM: #236500; PMID: 28295209, 32100459). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.03% (80/282750) and thus is presumed to be rare. Based on the available evidence, the c.256C>T (p.Arg86Ter) variant is classified as Pathogenic. -

not provided Pathogenic:2
Sep 01, 2023
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Published functional studies suggest a damaging effect on cilia disassembly (Zhang et al., 2019); This variant is associated with the following publications: (PMID: 30622327, 32100459, 28295209, 33475699) -

Sep 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg86*) in the CEP55 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP55 are known to be pathogenic (PMID: 28264986, 28295209, 30622327). This variant is present in population databases (rs141458677, gnomAD 0.06%). This premature translational stop signal has been observed in individual(s) with clinical features of Meckel-Gruber syndrome (PMID: 28295209, 32100459). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 437875). For these reasons, this variant has been classified as Pathogenic. -

Inborn genetic diseases Pathogenic:1
Dec 04, 2020
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.256C>T (p.R86*) alteration, located in exon 3 (coding exon 2) of the CEP55 gene, consists of a C to T substitution at nucleotide position 256. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 86. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This mutation was identified in the homozygous state in a fetus with Meckel-like syndrome; both parents and an unaffected sibling were heterozygous (Bondeson, 2017). This mutation was also detected in trans with a missense variant in two individuals with developmental delay, microcephaly/borderline microcephaly, and dysmorphic features (Barrie, 2020). Based on the available evidence, this alteration is classified as pathogenic. -

CEP55-related disorder Pathogenic:1
Sep 05, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The CEP55 c.256C>T variant is predicted to result in premature protein termination (p.Arg86*). This variant in the homozygous condition or along with a second variant in CEP55 was reported in two individuals with Meckel-like syndrome (Bondeson et al. 2017. PubMed ID: 28295209; Barrie et al. 2020. PubMed ID: 32100459). Functional studies suggest that this variant led to disrupted dynamic regulation of cilia formation (Zhang et al. 2021. PubMed ID: 33475699). This variant is reported in 0.056% of alleles in individuals of Latino descent in gnomAD. Nonsense variants in CEP55 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
35
DANN
Uncertain
1.0
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Benign
0.38
N
Vest4
0.83
GERP RS
2.4
Mutation Taster
=32/168
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141458677; hg19: chr10-95262942; COSMIC: COSV65184705; COSMIC: COSV65184705; API